Global Preimplantation Genetic Testing Market Report By Technology (Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Single Nucleotide Polymorphism (SNP), By Product & Service (Reagents & Consumables, Instruments, Software & Services), By Procedure Type (Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis), By Application (Aneuploidy Structural Chromosomal Abnormalities, Single Gene Disorders, X-linked Disorders, HLA Typing, Gender Identification), By End User (Maternity Centers & Fertility Clinics, Hospitals, Diagnostic Labs, and Service Providers, Research Laboratories & Academic Institutes) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

Name: Global Preimplantation Genetic Testing Market Report
Brand: Value Market Research
SKU: Healthcare
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11212794

April 2021

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

Global Preimplantation Genetic Testing Market Overview

The key driver impacting the preimplantation genetic testing market is the rising incidence of gene-related disorders creating demand for preimplantation diagnosis and screening processes. For instance, As per NCBI, Sickle cell disease (SCD) is one of the most common genetic hematological disorders. It accounts for 305000 births in 2010, with millions of people affected globally in 2018. The Center for Disease Control and Prevention (CDC) reports that Sickle Cell Disease affects over 100,000 Americans. Around one in every 365 African-American babies is born with Sickle Cell Disease in the U.S., Whereas one in every 16,300 Hispanic-American babies is diagnosed with sickle cell disease. The other most common genetic disorder is Cystic Fibrosis. As per the Cystic Fibrosis Foundation, More than 30,000 people are living with cystic fibrosis in the United States, more than 70,000 globally, and approximately 1,000 new CF cases are diagnosed each year. Moreover, growing technological advancements have enhanced the accuracy of prenatal screening and early detection of chromosomal abnormalities in an embryo, with affordable testing, contributing to market growth.

According to Value Market Research, the global preimplantation genetic testing market size was valued at around USD 500 Million by 2020 and is estimated to grow at a CAGR of about 10% during the forecast period 2021 to 2027.

The growing number of supportive initiatives adopted by the government authorities to promote reproductive health and approval for preimplantation genetic testing is estimated to augment preimplantation genetic testing demand in the forecast period. For instance, in June 2017, the Switzerland government had given the approval of the pre-implantation genetic diagnosis of an in-vitro embryo. In the U.S. The American Society for Reproductive Medicine (ASRM) also allowed the usage of PGD for preventing sex-linked diseases is ethical. However, the high costs associated with preimplantation genetic testing may hamper the global preimplantation genetic testing market in the long run. Also, the unfavorable government regulations negatively impact the market. The current industry trends, such as the technological progression in the field of genetic analysis and the high risk of chromosomal abnormalities with increased maternal age, are expected to provide market players with new market opportunities.

The preimplantation genetic testing market is vast, with many local and global players. The preimplantation genetic testing market is extensive, with many local and international players. The key leaders follow numerous strategies to increase their market position, such as extending product portfolio, contracts, amalgamation, extending product portfolio, product advancement, and acquisitions to improve their market share across the globe. For instance, In October 2019, PerkinElmer introduced PG-Seq Rapid Non-Invasive Pre-implantation Genetic Testing Kit for Aneuploidy application (PGT-A). It is a non-invasive option to traditional IVF embryo biopsies. The significant players studied in the report are Thermo Fisher Scientific, Inc., Laboratory Corporation of America Holdings, Good Start Genetics, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, California Pacific Medical Center, Quest Diagnostics Incorporated, Natera, Inc., Reproductive Health Science Ltd., CooperSurgical, Inc., Bioarray S.L., Genea Limited, Reproductive Genetic Innovations, LLC, IGENOMIX, CombiMatrix, and F. Hoffmann-La Roche AG.

In this research report, the preimplantation genetic testing market is segmented by product, procedure type, application, end-user, and region.

Analysis by Product:
By product, the report is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables dominate the product segment with a 40% share in 2020. The expanding application horizons of specific technologies (such as NGS and aCGH for whole-genome sequencing and FISH in diagnosing particular genetic disorders are majorly boosting the segment growth. Moreover, ease of use compared to conventional methods creates more demands for reagents & consumables segments in the forecast period.

Analysis by Procedure Type:
By procedure type, the report is segmented into preimplantation genetic screening(PGS) and preimplantation genetic diagnosis(PGD). The PGS dominate the procedure type segment with a 55% share in 2020. It is due to growing awareness about the screening of embryos for chromosomal abnormalities. It is best suited for couples with multiple IVF cycles, advanced reproductive age, and recurrent pregnancy loss. Moreover, many IVF processes are conducted in high-capacity laboratories due to the presence of better facilities, contributing to PGS technique segment growth in the forecast period.

Analysis by Application:
By application, the report is categorized into aneuploidy, structural chromosomal abnormalities, translocations, deletions, duplications, inversions, single-gene disorders, x-linked disorders, HLA typing, and gender identification. The aneuploidy application segment dominates the application segment with a 25% share in 2020. It is because aneuploidy screening during PGD has improved the IVF procedures that increase its demand. Moreover, the introduction of aneuploidy testing in IVF centers identifies abnormal embryos, resulting in successful pregnancy rates, contributing to the aneuploidy application segment's growth in the forecast period.

Analysis by End-User:
By end-user, the report is categorized into maternity centers & fertility clinics, hospitals, diagnostic labs, and service providers. The maternity centers & fertility clinics segment dominates the end-user segment with a 20% share in 2020. It is because IVF procedures and preimplantation genetic testing procedures are majorly conducted at fertility clinics and maternity centers. Moreover, growing awareness about assisted reproduction techniques and a growing number of fertility clinics worldwide contribute to the segment's growth in the forecast period.

Analysis by Region:
In the regional outlook of the global preimplantation genetic testing market, the North America region dominates with the most significant market share during the forecast period. It is due to the growing volume of chromosome abnormality cases leading to various genetic disorders. Also, the launch of new products by key players and a rise in healthcare infrastructure improvements in the United States generates more revenue. Moreover, the increase in government initiatives towards creating awareness among people and growing preference among couples for preimplantation genetic testing tests during IVF and other artificial insemination procedures contribute to the market's growth across North America.

Market Segmentation covered in the Report:
By Product

Reagents & Consumables
Instruments
Software & Services

By Procedure Type

Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis

By Application

By End User

Maternity Centers & Fertility Clinics
Hospitals, Diagnostic Labs, and Service Providers
Research Laboratories & Academic Institutes

By Region

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Preimplantation Genetic Testing Market
       2.2. Global Preimplantation Genetic Testing Market Snapshot

3 . PREIMPLANTATION GENETIC TESTING – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Preimplantation Genetic Testing Market
       3.3. Market Restraints of Preimplantation Genetic Testing Market
       3.4. Opportunities of Preimplantation Genetic Testing Market
       3.5. Trends of Preimplantation Genetic Testing Market
       3.6. Porter’s Five Force Analysis of Preimplantation Genetic Testing Market
       3.7. Preimplantation Genetic Testing Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Technology
           3.7.2 Market Attractive Analysis by Product & Service
           3.7.3 Market Attractive Analysis by Procedure Type
           3.7.4 Market Attractive Analysis by Application
           3.7.5 Market Attractive Analysis by End User
           3.7.6 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Preimplantation Genetic Testing Value Chain Analysis
       4.2. Preimplantation Genetic Testing Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Preimplantation Genetic Testing Raw Material Manufactures List
           4.2.3. Price Trend of Preimplantation Genetic Testing Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 IMPACT ANALYSIS OF COVID - 19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Preimplantation Genetic Testing Market
         5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Preimplantation Genetic Testing Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Preimplantation Genetic Testing Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Preimplantation Genetic Testing Market

6 . GLOBAL PREIMPLANTATION GENETIC TESTING MARKET ANALYSIS BY TECHNOLOGY
       6.1 Overview by Technology
       6.2 Historical Data 2015-2018
       6.3 Global Preimplantation Genetic Testing Market Analysis by Technology
       6.4 Market Analysis of Next Generation Sequencing (NGS) by Regions
       6.6 Market Analysis of Polymerase Chain Reaction (PCR) by Regions
       6.5 Market Analysis of Fluorescent In-Situ Hybridization (FISH) by Regions
       6.7 Market Analysis of Comparative Genomic Hybridization (CGH) by Regions
       6.8 Market Analysis of Single Nucleotide Polymorphism (SNP) by Regions

7 . GLOBAL PREIMPLANTATION GENETIC TESTING MARKET ANALYSIS BY PRODUCT & SERVICE
       7.1 Overview by Product & Service
       7.2 Historical Data 2015-2018
       7.3 Global Preimplantation Genetic Testing Market Analysis by Product & Service
       7.4 Market Analysis of Reagents & Consumables by Regions
       7.5 Market Analysis of Instruments by Regions
       7.6 Market Analysis of Software & Services by Regions

8 . GLOBAL PREIMPLANTATION GENETIC TESTING MARKET ANALYSIS BY PROCEDURE TYPE
       8.1 Overview by Procedure Type
       8.2 Historical Data 2015-2018
       8.3 Global Preimplantation Genetic Testing Market Analysis by Procedure Type
       8.4 Market Analysis of Preimplantation Genetic Screening by Regions
       8.5 Market Analysis of Preimplantation Genetic Diagnosis by Regions

9 . GLOBAL PREIMPLANTATION GENETIC TESTING MARKET ANALYSIS BY APPLICATION
       9.1 Overview by Application
       9.2 Historical Data 2015-2018
       9.3 Global Preimplantation Genetic Testing Market Analysis by Application
       9.4 Market Analysis of Aneuploidy by Regions
       9.5 Market Analysis of Structural Chromosomal Abnormalities by Regions
       9.6 Market Analysis of Single Gene Disorders by Regions
       9.7 Market Analysis of X-linked Disorders by Regions
       9.8 Market Analysis of HLA Typing by Regions
       9.9 Market Analysis of Gender Identification by Regions

10 . GLOBAL PREIMPLANTATION GENETIC TESTING MARKET ANALYSIS BY END USER
       10.1 Overview by End User
       10.2 Historical Data 2015-2018
       10.3 Global Preimplantation Genetic Testing Market Analysis by End User
       10.4 Market Analysis of Maternity Centers & Fertility Clinics by Regions
       10.5 Market Analysis of Hospitals, Diagnostic Labs, and Service Providers by Regions
       10.6 Market Analysis of Research Laboratories & Academic Institutes by Regions

11 . GLOBAL PREIMPLANTATION GENETIC TESTING MARKET ANALYSIS BY GEOGRAPHY
       11.1. Regional Outlook
       11.2. Introduction
       11.3. North America
           11.3.1. Overview and Historic Data
           11.3.2. North America Preimplantation Genetic Testing Market Estimate By Market Segment
           11.3.3. North America Preimplantation Genetic Testing Market Estimate By Country
           11.3.4. United State
           11.3.5. Canada
           11.3.6. Mexico
       11.4. Europe
           11.4.1. Overview and Historic Data
           11.4.2. Europe Preimplantation Genetic Testing Market Estimate by Market Segment
           11.4.3. Europe Preimplantation Genetic Testing Market Estimate by Country
           11.4.4. United Kingdom
           11.4.5. France
           11.4.6. Germany
         11.4.7. Italy
           11.4.8. Russia
           11.4.9. Rest Of Europe
       11.5. Asia Pacific
           11.5.1. Overview and Historic Data
           11.5.2. Asia Pacific Preimplantation Genetic Testing Market Estimate by Market Segment
           11.5.3. Asia Pacific Preimplantation Genetic Testing Market Estimate by Country
           11.5.4. China
           11.5.5. India
           11.5.6. Japan
           11.5.7. South Korea
           11.5.8. Australia
           11.5.9. Rest Of Asia Pacific
       11.6. Latin America
           11.6.1. Overview and Historic Data
           11.6.2. Latin America Preimplantation Genetic Testing Market Estimate by Market Segment
           11.6.3. Latin America Preimplantation Genetic Testing Market Estimate by Country
           11.6.4. Brazil
           11.6.5. Argentina
           11.6.6. Peru
           11.6.7. Chile
           11.6.8. Rest of Latin America
       11.7. Middle East & Africa
           11.7.1. Overview and Historic Data
           11.7.2. Middle East & Africa Preimplantation Genetic Testing Market Estimate by Market Segment
           11.7.3. Middle East & Africa Preimplantation Genetic Testing Market Estimate by Country
           11.7.4. Saudi Arabia
           11.7.5. UAE
           11.7.6. Israel
           11.7.7. South Africa
           11.7.8. Rest Of Middle East And Africa

12 . COMPETITIVE LANDSCAPE OF THE PREIMPLANTATION GENETIC TESTING COMPANIES
       12.1. Preimplantation Genetic Testing Market Competition
       12.2. Partnership/Collaboration/Agreement
       12.3. Merger And Acquisitions
       12.4. New Product Launch
       12.5. Other Developments

13 COMPANY PROFILES OF PREIMPLANTATION GENETIC TESTING INDUSTRY
       13.1. Company Share Analysis
       13.2. Market Concentration Rate
       13.3. Thermo Fisher Scientific, Inc.
           13.3.1. Company Overview
           13.3.2. Financials
           13.3.3. Products
           13.3.4. Recent Developments
       13.4. Agilent Technologies, Inc.
           13.4.1. Company Overview
           13.4.2. Financials
           13.4.3. Products
           13.4.4. Recent Developments
       13.5. PerkinElmer, Inc.
           13.5.1. Company Overview
           13.5.2. Financials
           13.5.3. Products
           13.5.4. Recent Developments
       13.6. CooperSurgical, Inc.
           13.6.1. Company Overview
           13.6.2. Financials
           13.6.3. Products
           13.6.4. Recent Developments
       13.7. Beijing Genomics Institute
           13.7.1. Company Overview
           13.7.2. Financials
           13.7.3. Products
           13.7.4. Recent Developments
       13.8. Abbott Laboratories
           13.8.1. Company Overview
           13.8.2. Financials
           13.8.3. Products
           13.8.4. Recent Developments
       13.9. Natera, Inc.
           13.9.1. Company Overview
           13.9.2. Financials
           13.9.3. Products
           13.9.4. Recent Developments
       13.10. Genea Limited
           13.10.1. Company Overview
           13.10.2. Financials
           13.10.3. Products
           13.10.4. Recent Developments
       13.11. Rubicon Genomics, Inc.
           13.11.1. Company Overview
           13.11.2. Financials
           13.11.3. Products
           13.11.4. Recent Developments
       13.12. Oxford Gene Technology
           13.12.1. Company Overview
           13.12.2. Financials
           13.12.3. Products
           13.12.4. Recent Developments

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "